바이오프로세스 용기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 용기 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Bioprocess Containers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Containers, By Application, By End Users, By Region and Competition, 2020-2030F
상품코드:1770898
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 바이오프로세스 용기 시장은 2024년에 46억 8,000만 달러로 평가되었으며, 예측 기간 동안 CAGR 22.57%로 성장하여 2030년까지 158억 7,000만 달러에 달할 것으로 예측됩니다.
시장의 급격한 성장은 혁신적인 치료 제품 개발을 지원하는 첨단 기술의 도입과 함께 바이오 제약 부문에서 자동화 및 기계 학습의 도입이 증가하고 있는 것이 주요 요인으로 작용하고 있습니다. 바이오프로세스 용기는 의약품 제조에 있어 기존의 스테인리스 스틸 시스템을 대체할 수 있는 비용 효율적이고 신뢰할 수 있는 시스템입니다. 일회용 디자인은 유연성을 제공하고, 오염 위험을 줄이며, 세척의 필요성을 최소화합니다. 이러한 용기는 확장성과 높은 운영 효율성으로 인해 바이오 제조 분야에서 점점 더 선호되고 있습니다. 최근 스마트 센서 및 IoT 기반 기능이 통합되어 바이오 공정 환경에서 공정 모니터링 및 제어를 더욱 강화하는 추세입니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
46억 8,000만 달러
시장 규모 : 2030년
158억 7,000만 달러
CAGR : 2025-2030년
22.57%
급성장 부문
3D 바이오프로세스 용기
최대 시장
북미
주요 시장 촉진요인
바이오의약품 연구개발 및 맞춤형 의료 확대
주요 시장 과제
환경 문제 및 폐기물 관리
주요 시장 동향
스마트 기술과 IoT의 통합
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
용기 유형별(2D 바이오프로세스 컨테이너, 3D 바이오프로세스 컨테이너, 기타 컨테이너·액세서리)
용도별(업스트림, 다운스트림, 프로세스 개발)
최종사용자별(바이오의약품 기업, 생명과학 연구개발 기업, 기타)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
시장 맵
용기 유형별
용도별
최종사용자별
지역별
제6장 북미의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 바이오프로세스 용기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병
제품 출시
제13장 세계의 바이오프로세스 용기 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Thermo Fisher Scientific Inc.
Danaher Corporation
Saint-Gobain Group
Lonza Group AG
Avantor Funding Inc.
Merck KGaA
Sartorius AG
CellBios Healthcare and Lifesciences Pvt Ltd.
Cole-Parmer Instrument Co.
Biomass Ventures Pte Ltd.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Bioprocess Containers Market was valued at USD 4.68 billion in 2024 and is projected to reach USD 15.87 billion by 2030, growing at a CAGR of 22.57% during the forecast period. The market's rapid expansion is primarily driven by the increasing adoption of automation and machine learning within the biopharmaceutical sector, alongside the introduction of advanced technologies supporting the development of innovative therapeutic products. Bioprocess containers serve as a cost-efficient and reliable alternative to traditional stainless-steel systems in drug manufacturing. Their single-use design offers flexibility, reduces contamination risk, and minimizes cleaning requirements. These containers are increasingly favored in biomanufacturing due to their scalability and operational efficiency. Recent developments have also seen the integration of smart sensors and IoT-based functionalities, further enhancing process monitoring and control within bioprocessing environments.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 4.68 Billion
Market Size 2030
USD 15.87 Billion
CAGR 2025-2030
22.57%
Fastest Growing Segment
3D Bioprocess Containers
Largest Market
North America
Key Market Drivers
Expansion of Biopharmaceutical R&D and Personalized Medicine
The growing investment in biopharmaceutical research and personalized medicine is a major driver fueling demand for bioprocess containers. These containers, particularly single-use systems, offer key advantages such as reduced contamination risk, scalability, and operational flexibility-features essential for the evolving needs of biopharmaceutical production.
Significant funding initiatives are supporting this trend. In 2024, the U.S. National Institutes of Health (NIH) allocated over $47 billion to medical research, focusing on gene therapies and personalized treatments. Likewise, the European Union's Horizon Europe program earmarked €95.5 billion for innovation and health research between 2021 and 2027.
These investments are catalyzing the development of complex biologics, including monoclonal antibodies, cell therapies, and vaccines. Bioprocess containers play a vital role in this space, offering sterile, disposable solutions that help accelerate production timelines and reduce cross-contamination, thus supporting the efficient delivery of personalized medical solutions.
Key Market Challenges
Environmental Concerns and Waste Management
Despite operational advantages, the single-use nature of bioprocess containers presents a significant environmental challenge due to the generation of plastic-based biomedical waste. The disposal of these materials raises sustainability concerns across the biopharmaceutical industry.
Global regulatory bodies are placing increased emphasis on sustainable manufacturing. For example, the European Union has enacted directives to reduce plastic waste and promote recyclable or biodegradable alternatives. In the United States, the Environmental Protection Agency (EPA) is driving initiatives to manage plastic waste and encourage eco-friendly practices.
However, recycling bioprocess containers remains complex due to contamination risks and material limitations. The lack of standardized disposal protocols and viable recycling infrastructure makes it difficult for manufacturers to meet environmental compliance goals. As a result, the market faces mounting pressure to develop innovative materials and waste mitigation strategies that align with growing sustainability expectations.
Key Market Trends
Integration of Smart Technologies and IoT
The incorporation of smart technologies and IoT into bioprocess containers is transforming modern biomanufacturing. Smart containers equipped with real-time sensors and digital connectivity are enabling manufacturers to monitor critical process parameters such as temperature, pH, and pressure with high precision.
Governmental support for digital innovation in manufacturing is reinforcing this trend. The U.S. Department of Commerce's NIST and the European Commission's Industry 5.0 initiative both promote the adoption of intelligent systems to enhance industrial efficiency and adaptability.
This movement aligns with the broader evolution toward Industry 4.0, where automation, data analytics, and machine-to-machine communication are key drivers of operational excellence. Smart bioprocess containers enable predictive maintenance, improve traceability, reduce downtime, and support regulatory compliance-collectively enhancing product quality and manufacturing efficiency.
Key Market Players
Thermo Fisher Scientific Inc.
Danaher Corporation
Saint-Gobain Group
Lonza Group AG
Avantor Funding Inc.
Merck KGaA
Sartorius AG
CellBios Healthcare and Lifesciences Pvt Ltd.
Cole-Parmer Instrument Co.
Biomass Ventures Pte Ltd.
Report Scope:
In this report, the Global Bioprocess Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Bioprocess Containers Market, By Type of Containers:
2D Bioprocess Containers
3D Bioprocess Containers
Other Containers and Accessories
Bioprocess Containers Market, By Application:
Upstream Process
Downstream Process
Process Development
Bioprocess Containers Market, By End Users:
Biopharmaceutical Companies
Life Science R&D Companies
Others
Bioprocess Containers Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.
Available Customizations:
Global Bioprocess Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Bioprocess Containers Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Market Map
5.3.1 By Type of Containers
5.3.2 By Application
5.3.3 By End Users
5.3.4 By Region
6. North America Bioprocess Containers Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Bioprocess Containers Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Containers
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Bioprocess Containers Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Containers
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Bioprocess Containers Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Containers
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Bioprocess Containers Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Bioprocess Containers Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Containers
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Bioprocess Containers Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Containers
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Bioprocess Containers Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Containers
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Bioprocess Containers Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Containers
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Bioprocess Containers Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Containers
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Bioprocess Containers Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Bioprocess Containers Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Containers
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Bioprocess Containers Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Containers
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Bioprocess Containers Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Containers
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Bioprocess Containers Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Containers
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Bioprocess Containers Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Containers
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Bioprocess Containers Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Bioprocess Containers Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Containers
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Bioprocess Containers Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Containers
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Bioprocess Containers Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Containers
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Bioprocess Containers Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Bioprocess Containers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Containers
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Containers
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Bioprocess Containers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Containers
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Bioprocess Containers Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Thermo Fisher Scientific Inc.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Danaher Corporation
15.3. Saint-Gobain Group
15.4. Lonza Group AG
15.5. Avantor Funding Inc.
15.6. Merck KGaA
15.7. Sartorius AG
15.8. CellBios Healthcare and Lifesciences Pvt Ltd.
